(Q32053101)

5 July 2017

Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status (English)

1 reference

5 July 2017

0 references

Beauregard DA

1

1 reference

5 July 2017

Thelwall PE

2

1 reference

5 July 2017

Chaplin DJ

3

1 reference

5 July 2017

Hill SA

4

1 reference

5 July 2017

Adams GE

5

1 reference

5 July 2017

Brindle KM

6

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

British Journal of Cancer

5 July 2017

1 reference

5 July 2017

77

1 reference

5 July 2017

11

1 reference

5 July 2017

1761-1767

1 reference

Antivascular approaches to solid tumour therapy: evaluation of tubulin binding agents

5 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150333

The apparent diffusion constant measured by MRI correlates with pO2 in a RIF-1 tumor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150333

Time-dependent diffusion of water in a biological model system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150333

Observation of tissue metabolites using 31P nuclear magnetic resonance

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150333

Magnetic resonance imaging of stationary blood: a review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150333

Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150333

Response of solid tumors to chemotherapy monitored by in vivo 31P nuclear magnetic resonance spectroscopy: a review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150333

The contribution made by cell death and oxygenation to 31P MRS observations of tumour energy metabolism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150333

Studies of human tumors by MRS: a review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150333

Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature

21 June 2018

1 reference

12 December 2020

Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study

1 reference

12 December 2020

Iteration of hybridoma growth and productivity in hollow fiber bioreactors using31P NMR

1 reference

12 December 2020

An assessment of31P MRS as a method of measuring pH in rat tumours

1 reference

12 December 2020

Quantitative MRI of Gd-DTPA uptake in tumors: response to photodynamic therapy

1 reference

12 December 2020

Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugs

1 reference

12 December 2020

Quantitative diffusion imaging in implanted human breast tumors

1 reference

12 December 2020

Vascular occlusion and tumour cell death

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1998.294

1 reference

Dimensions Publication ID

5 July 2017

0 references

1 reference

5 July 2017

1 reference